Ancora.ai is a Switzerland-based startup with a vision to revolutionize cancer patient care by providing access to clinical research through their patient-first, digital clinical trials hub. Their precision medicine trial matching technology personalizes trial results for cancer patients in minutes, reducing the burden of clinical trial referrals across the healthcare ecosystem and accelerating recruitment timelines. Recently, they secured a Fr.30.00K grant investment from Future of Health Grant in February 09, 2023. Ancora.ai is committed to democratizing access to trials, and they are actively seeking strong partners who share their vision to bring innovation and improved accessibility to clinical trials. Their focus on Big Data, Health Care, Pharmaceutical, and SaaS industries underlines their commitment to utilizing advanced technology for the benefit of cancer patients worldwide. Follow their journey on Twitter at @ancora_ai and Instagram at @ancora.ai.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | Fr.30.00K | 1 | Future of Health Grant | 09 Feb 2023 |
Non Equity Assistance | Unknown | 1 | Google for Startups | 15 Jun 2022 |
Pre Seed Round | $315.00K | - | 31 Oct 2021 | |
Grant | €50.00K | 1 | EIT Health | 26 Jun 2020 |
Grant | €20.00K | - | 26 May 2020 |
No recent news or press coverage available for Ancora.ai.